Activity of lysosomal exoglycosidases in human gliomas

Journal of Neuro-Oncology

Volumn 80, Issue 3, 2006, Pages 243-249

  Wielgat, P ^a   Walczuk, U ^a   Szajda, S ^a   Bien M ^a   Zimnoch, L ^a   Mariak, Z ^a   Zwierz, K ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Brain tumors; Gliomas; Lysosomal glycosidases; Malignancy

Indexed keywords

4 NITROPHENOL; ALPHA MANNOSIDASE; BETA GALACTOSIDASE; BETA N ACETYLHEXOSAMINIDASE A; BETA N ACETYLHEXOSAMINIDASE B;

ARTICLE; ASTROCYTOMA; CANCER GRADING; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE COURSE; DISEASE SEVERITY; ENZYME ACTIVITY; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN TISSUE; MENINGIOMA; OLIGODENDROGLIOMA; SPECTROPHOTOMETRY;

ALPHA-MANNOSIDASE; BETA-GALACTOSIDASE; BETA-N-ACETYLHEXOSAMINIDASE; BRAIN NEOPLASMS; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; GLYCOSIDE HYDROLASES; HUMANS; ISOENZYMES;

EID: 33751214537     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-006-9188-z     Document Type: Article

References (64)

1. Xiao-Hong Z, Brakebusch C, Matthies H, Oohashi T, Hirsch E, Moser M, Krug M, Seidenbecher CI, Boeckers TM, Rauch U, Buettner R (2001) Neurocan is dispesable for brain development. Mol Cell Biol 7:5970-5978
2. Margolis RK, Rauch U, Maurel P, Margolis RU (1996) Neurocan and phosphacan: Two major nervous tissue - specific chondroitin sulfate proteoglycans. Perspect Dev Neurobiol 3:273-290
3. Landlot RM, Vaurhan L, Winterhalter KH, Zimmermann DR (1995) Versican is selectively expressed in embryonic tissues that act as barriers to neural crest cell migration and axon outgrowth. Development 121:2303-2312
4. Cavalcante LA, Garcia-Abreu J, Mendes FA, Mouro Neto V, Silva LCF, Onofre G, Weissmüller G, Carvahlo SL (2003) Sulfated proteoglycans as modulators of neuronal migration and axonal decussation in the developing midbrain. Braz J Med Biol Res 36:993-1002
5. Bandtlow CE, Zimmermann DR (2002) Proteoglycans in the developing brain: new conceptual insights for old proteins. Physiol Rev 80(4):1267-1282
6. Agranoff BW (1989) Lipids. In: Siegel G, Agranoff BW, Albers RW, Molinoff P (eds) Basic neurochemisty, 4th edn. Raven Press, New York
7. Rhodes KE, Fawcett JW (2004) Chondroitin sulphate proteoglycans: preventing plasticy or protecting the CNS? J Anat 204:33-48
8. Properzi F, Fawcett JW (2002) Proteoglycans and brain repair. News Physiol Sci 19:33-38
9. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P (2002) Molecular biology of the cell, 4th edn. Garland Science, New York
10. Prokopowicz J, Dabrowska M, Kemona H (1990) Proteases and antiproteases in cancer. Nowotwory 2:88-93
11. Miyagi T, Wada T, Yamaguchi K, Hata K (2004) Sialidase and malignancy: A minireview. Glycoconj J 20:189-198
12. Levin VA, Gutin PH, Leibel S (1993) Neoplasms of the central nervous system. In: De Vita VT, Hellman S, Rosenberg SA, JB Cancer Principle and practice of oncology. Lipincott Company, 4th edn, pp 1679-1737
13. Kheihues P, Burger PC, Scheithauer BW (1993) The new classification WHO of brain tumors. Brain Pathol 3:255-268
14. Kiwit JC, Floeth FW, Bock WJ (1996) Survival in malignant glioma: analysis of prognostic factors with special regard to cytoreductive surgery. Neurochir 57(2):76-88
15. Levin VA, Silver P, Hannigan J, Wara WM, Gutin PW, Davis RL, Wilson CD (1990) Superiority of post-radiotherapy adjuvant chemotheraphy with CCNU, procarbasine, and vincristine (PCV) over BCNU for anaplastic gliomas NCOG 6G61 final report. Int J Radiat Oncol Biol Phys 18:321-324
16. Daumas-Duport C (1992) Histological grading of gliomas. Curr Opin Neurol Neurosurg 5:924-931
17. Plucinsky MC, Prorok JJ, Alhadeff JA (1986) Variant serum beta-hexosaminidase as a biochemical marker of malignancy. Cancer 1 58(7):1484-1487
18. Kunishio K, Okada M, Matsumoto Y, Nagao S (2003) Matrix metalloproteinase-2 and -9 expression in astrocytic tumors. Brain Tumor Pathol 20:39-45
19. Borzym-Kluczyk M, Darewicz B, Knas M, Szajda SD, Olszewska E, Zwierz K (2005) The activity of N-acetyl-beta-Glucosaminidase and its isoenzymes in the renal tissue, serum and urine of patients with renal cancer. Wspolczesna Onkol 9:287-290
20. Kakugawa Y, Wada T, Yamaguchi K, Yamanami H, Ouchi K, Sato I, Miyagi T (2002) Up-regulation of plasma membrane-associated ganglioside sialidase (Neu3) in human colon and its involvement in apoptosis suppression. Proc Natl Acad Sci USA 99:10,718-10,723
21. Ochwat D, Hoja-Lukowicz D, Litynska A (2004) N-glycoproteins bearing β-6 branched oligosaccharides from the A375 human melanoma cell iline analysed by tandem mass spectrometry. Melanoma Res 14:479-485
22. Kim YS, Isaacs R (1975) Glycoprotein metabolism in inflammatory and neoplastic diseases of the human colon. Cancer Res 35(8):2092-2097
23. Vlodavsky I, Friedmann Y (2001) Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J Clin Invest 108(3): 341-347
24. Yates AJ, Comas T, Scheithauer BW, Burger PC, Pearl DK (1999) Glycolipids markers of astrocytomas and oligodendrogliomas. J Neuropathol Exp Neurol 58:1250-1262
25. Buck MR, Karustis DG, Day NA, Honn KV, Sloane BF (1992) Degradation of extracellular - matrix proteins by human cathepsin B from normal and tumour tissues. Biochem J 15(282):273-278
26. Campanella R (1992) Membrane lipids modifications in human gliomas of different degree of malignancy. J Neurosurg Sci 36:11-25
27. Wagener R, Rohn G, Schroder R, Kobbe B, Ernestus RI (1999) Ganglioside profile in human gliomas: Quantification by microbore high performance liquid chromatography and correlation to histopathology and grading. Acta Neurochir (Wien) 141:1339-1345
28. Chang F, Li R, Noon K, Gage D, Ladisch S (1997) Human medulloblastoma gangliosides. Glycobiology 7:523-530
29. Hynes RD (1976) Cell surface proteins and malignant transformation. Biochim Biophys Acta 458:73-107
30. Noll EN, Lin J, Nakatsuji Y, Miller RH, Black PM (2001) GM3 as a novel growth regulator for human gliomas. Exp Neurol 168:300-309
31. Nygren C, von Holst H, Mansson JE, Fredman P (1994) Increased activity of lysosomal glycohydrolases in glioma tissues and surrounding areas from human brain. Acta Neurochir 139(2):146-150
32. Zwierz K, Zalewska A, Zoch-Zwierz W (1999) Isoenzymes of N-acetyl-β-hexosaminidase. Acta Biochim Polon 3:739-757
33. Bernacki RJ, Niedbala MJ, Korytnyk W (1985) Glycosidases in cancer and invasion. Cancer Matastasis Rev 4:81-101
34. Pochec E, Litynska A, Bubka M, Amoresano A, Casbarra A (2006) Characterization of the oligosaccharide component of α3β1 integrin from human bladder carcinoma cell line T24 and its role in adhesion and migration. Eur J Cell Biol 85:47-57
35. Naka R, Kamoda S, Isuzuka A, Kinoshita M, Kakehi K (2006) Analysis of total N-glycans in cell membrane fractions of cancer cells using a combination of serotonin affinity chromatography and normal phase chromatography. J Proteome Res 5:88-97
36. Rebbaa A, Chou PM, Vucic I, Mirkin BL, Tomita T, Bremer EG (1999) Expression of bisecting GlcNAc in pediatric brain tumors and its association with tumor cell response to vinblastine. Clin Cancer Res 5:3661-3668
37. Viapiano MS, Bi WL, Piepmeier J, Hockfield S, Matthews RT (2005) Novel tumor-specific isoforms of BEHAB/brevican identified in human malignant gliomas. Cancer Res 65: 6726-6733
38. Suzuki O, Nozawa Y, Abe M (2006) The regulatory roles of cell surface sialylation and N-glycans in human B cell lymphoma cell adhesion to galectin-1. Int J Oncol 28:155-160
39. Sato T, Takahashi M, Kewado T, Takayama E, Furukawa K (2005) Effect of staurosporine on N-glycosylation and cell adhesion to fibronectin of SW480 human colorectal adenocarcinoma cells. Eur J Pharm Sci 25:221-227
40. Krishnan V, Bane SM, Kawle PD, Naresh KN, Kalraiya RD (2005) Altered melanoma cell surface glycosylation mediates organ specific adhesion and metastasis via lectin receptors on the lung vascular endothelium. Clin Exp Metastasis 22:11-24
41. Ciolczyk-Wierzbicka D, Amoresano A, Casbarra A, Hoja-lukowicz D, Litynska A, Laidler P (2004) The structure of the oligosaccharides of N-cadherin from human melanoma cell lines. Glycoconj J 20:483-492
42. Glick MC (1976) Glycoproteins on the surface of neuroblastoma cells. J Natl Cancer Inst 57:653-658
43. Yamamoto H, Oveido A, Sweeley C, Saito T, Moskal JR (2001) Alpha2,6-sialylation of cell-surface N-glycans inhibits glioma formation in vivo. Cancer Res 61:6822-6829
44. Spillmann D, Finne J (1987) Poly-N-acetyllactosamine glycans of cellular glycoproteins: Predominance of linear chains in mouse neuroblastoma and rat pheochromocytoma cell lines. J Neurochem 49:874-883
45. Dawson G, Moskal JR, Dawson SA (2004) Transfection of 2,6 and 2,3-sialyltransferase genes into human glioma cell line U-373MG affects glycoconjugate expression and enhances cell death. J Neurochem 89:1436-1444
46. Chatterjee SK, Chowdhury K, Bhattarya M, Barlow JL (1982) β-Hexosaminidase activities and isoenzymes in normal human ovary and ovarian carcinoma. Cancer 49:128-135
47. Brattain MG, Kimball PM, Pretlow TG (1977) β-Hexosaminidase isoenzymes in human colonic carcinoma. Cancer Res 37:731-735
48. Bosmann HB, Hall TC (1974) Enzyme activity in invasive tumors of human breast and colon. Proc Natl Acad Sci USA 71:1833-1837
49. Bhuvarahumurthy V, Govindsamy S (1996) Purification and characterization of hexosaminidase from human uterine cervical carcinoma. Gynecol Oncol 60:188-196
50. Luqmani Y, Temmim. L, Memon A, Abdulaziz L, Parkar A, Ali M, Motowy M, Fayaz S (1999) Measurement of serum N-acetyl-β-glucosaminidase activity in patients with breast cancer. Acta Oncol 38:649-653
51. Zwierz K, Gindzienski A, Głowacka D, Porowski T (1951) The degradation of glycoconjugates in the human gastric mucous membrane. Acta Med Acad Sci Hung 38(2):145-152
52. Lowry OH, Rosebrough NJ, Farr AL (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
53. Florkin M, Stotz EH (1973) Enzyme nomenclature. In: Comprehensive biochemistry, vol 13. Elsevier, Amsterdam, London, New York
54. Allen N, Clendenon NR, Abe H (1977) Acid hydrolase and cytochrome oxidase activities in nitrosourea-induced tumors of nervous system. Acta Neuropathol 39:13-23
55. Avrova NF, Tyurin VA, Tyurina YY, Gamaley IA, Schepetkin IA (2002) Different metabolic effects of ganglioside GM1 in brain synaptosomes and phagocytic cells. Neurochem Res 27:751-759
56. Bansal R, Winkler S, Bheddah S (1999) Negative regulation of oligodendrocyte differentiation by galactosphingolipids. J Neurosci 19:7913-7924
57. Vaguero J, Morales C, Zurita M, Oya S (1994) Gangliosides modulate the development of ethyl-nitrosourea induced brain tumors. Neurosci Lett 25:37-40
58. Chekenaya M, Rooprai HK, Davies D, Levine JM, Butt AM, Pikington GJ (1999) The NG2 chondroitin sulfate proteoglycan: Role in malignant progression of human brain tumors. Int J Dev Neurosci 17:421-435
59. Wolanska M, Sobolewski K, Cechowska-Pasko M, Jaworski S (2003) The activities of some glycosaminoglycans - degrading enzymes in uterine leiomyomas. Eur J Obst Gyn Rep Biol 110:73-78
60. Ramsey RB, Smith KR, Crafts DC, Chung HD, Fredericks M (1980) Hydrolytic enzyme activities of the nervous system. Arch Neurol 37:356-359
61. Tiby V, Lombardo A, Goi G, Tettamanti G, Gaini SM, Canal N (1984) Study of some lysosomal glycohydrolases in tumors of the nervous system. Res Commun Chem Pathol Pharmacol 44:149-161
62. Ernst S, Langer R, Cooney CL, Sasisekhran R (1995) Enzymatic degradation of glycosaminoglycans. Crit Rev Biochem Mol Biol 30:387-444
63. Wolanska M, Sobolewski K, Drozdzewicz M, Bankowski E (1998) Extracellular matrix components in uterine leiomyoma and their alteration during the tumour growth. Mol Cell Biochem 189:145-152
64. Sulowicz W, Lisiewicz J, Kuźniewski M, Strzałka H (1985) Activity of some lysosomal enzymes in peripheral blood lymphocytes of patients with lung cancer. A cytochemical study. Folia Haemat 112:63-70